 David Orlicky
Concepts (869)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver | 41 | 2022 | 1844 | 2.280 |
Why?
| | Lipid Metabolism | 18 | 2020 | 529 | 1.620 |
Why?
| | Non-alcoholic Fatty Liver Disease | 9 | 2020 | 259 | 1.570 |
Why?
| | Ethanol | 17 | 2022 | 728 | 1.550 |
Why?
| | Mice | 104 | 2022 | 15481 | 1.460 |
Why?
| | Hepatocytes | 7 | 2021 | 205 | 1.430 |
Why?
| | Perilipin-2 | 13 | 2019 | 52 | 1.420 |
Why?
| | Animals | 151 | 2022 | 34758 | 1.260 |
Why?
| | Cholestasis | 8 | 2021 | 206 | 1.260 |
Why?
| | Liver Diseases, Alcoholic | 9 | 2022 | 87 | 1.240 |
Why?
| | Receptors, Prostaglandin | 13 | 1998 | 25 | 1.150 |
Why?
| | Oxidative Stress | 23 | 2022 | 1231 | 1.110 |
Why?
| | Fatty Liver | 12 | 2021 | 275 | 1.060 |
Why?
| | Dinoprost | 15 | 1996 | 34 | 1.050 |
Why?
| | Mice, Inbred C57BL | 49 | 2022 | 5151 | 1.050 |
Why?
| | Obesity | 14 | 2021 | 2649 | 1.020 |
Why?
| | Ligaments | 2 | 2020 | 39 | 0.980 |
Why?
| | Fatty Liver, Alcoholic | 5 | 2021 | 18 | 0.970 |
Why?
| | Uterus | 4 | 2020 | 193 | 0.940 |
Why?
| | Adipocytes | 6 | 2018 | 196 | 0.850 |
Why?
| | Pelvic Organ Prolapse | 2 | 2020 | 34 | 0.850 |
Why?
| | Aldehyde Dehydrogenase | 7 | 2017 | 136 | 0.820 |
Why?
| | Sacrum | 1 | 2020 | 52 | 0.800 |
Why?
| | Cytoplasm | 6 | 2016 | 298 | 0.790 |
Why?
| | Mice, Knockout | 32 | 2022 | 2835 | 0.780 |
Why?
| | Protein Carbonylation | 8 | 2018 | 52 | 0.780 |
Why?
| | Acetaminophen | 5 | 2022 | 245 | 0.770 |
Why?
| | Fructokinases | 7 | 2021 | 64 | 0.750 |
Why?
| | Liver Cirrhosis, Experimental | 1 | 2019 | 12 | 0.740 |
Why?
| | Milk | 7 | 2019 | 139 | 0.740 |
Why?
| | Metabolic Syndrome | 6 | 2021 | 391 | 0.740 |
Why?
| | Aldehydes | 9 | 2019 | 169 | 0.720 |
Why?
| | Bile Acids and Salts | 6 | 2022 | 168 | 0.720 |
Why?
| | Chemical Warfare Agents | 6 | 2014 | 100 | 0.700 |
Why?
| | Disease Models, Animal | 28 | 2021 | 3826 | 0.680 |
Why?
| | Fructose | 7 | 2021 | 199 | 0.670 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 4 | 2021 | 207 | 0.670 |
Why?
| | Skin | 9 | 2019 | 680 | 0.670 |
Why?
| | Dietary Fats | 5 | 2022 | 362 | 0.660 |
Why?
| | Kidney | 8 | 2019 | 1203 | 0.650 |
Why?
| | Mechlorethamine | 5 | 2015 | 65 | 0.640 |
Why?
| | Neoplasm Proteins | 10 | 2005 | 435 | 0.630 |
Why?
| | Membrane Proteins | 12 | 2016 | 1092 | 0.600 |
Why?
| | Lactation | 10 | 2019 | 217 | 0.590 |
Why?
| | Organelles | 2 | 2013 | 53 | 0.590 |
Why?
| | Diet, High-Fat | 9 | 2020 | 266 | 0.570 |
Why?
| | Glutathione Transferase | 6 | 2019 | 116 | 0.570 |
Why?
| | Mammary Glands, Animal | 7 | 2019 | 181 | 0.570 |
Why?
| | PTEN Phosphohydrolase | 4 | 2018 | 140 | 0.540 |
Why?
| | Mitochondria | 6 | 2019 | 819 | 0.530 |
Why?
| | DNA Damage | 7 | 2021 | 371 | 0.490 |
Why?
| | Prostaglandins F | 6 | 1988 | 17 | 0.490 |
Why?
| | Alcohol Drinking | 4 | 2016 | 718 | 0.480 |
Why?
| | Liver Diseases | 4 | 2021 | 274 | 0.480 |
Why?
| | Parenteral Nutrition | 3 | 2021 | 84 | 0.470 |
Why?
| | Peptides | 3 | 2008 | 865 | 0.460 |
Why?
| | Receptors, Virus | 2 | 2003 | 82 | 0.450 |
Why?
| | Chemical and Drug Induced Liver Injury | 4 | 2022 | 138 | 0.450 |
Why?
| | Superoxide Dismutase | 6 | 2019 | 337 | 0.440 |
Why?
| | Mustard Gas | 5 | 2014 | 87 | 0.430 |
Why?
| | Adenoviridae | 2 | 2003 | 184 | 0.430 |
Why?
| | Inflammatory Bowel Diseases | 3 | 2020 | 252 | 0.430 |
Why?
| | Transfection | 8 | 2016 | 964 | 0.420 |
Why?
| | Antioxidants | 8 | 2019 | 560 | 0.410 |
Why?
| | Male | 61 | 2022 | 60974 | 0.410 |
Why?
| | Carcinoma, Basal Cell | 2 | 2022 | 63 | 0.400 |
Why?
| | Lens, Crystalline | 2 | 2022 | 124 | 0.400 |
Why?
| | Diabetes Mellitus, Experimental | 3 | 2017 | 206 | 0.400 |
Why?
| | Endometrium | 6 | 1988 | 75 | 0.400 |
Why?
| | Inflammation | 13 | 2022 | 2458 | 0.400 |
Why?
| | Glutathione Reductase | 3 | 2019 | 27 | 0.390 |
Why?
| | Nitric Oxide Synthase Type I | 2 | 2020 | 26 | 0.390 |
Why?
| | Thioredoxins | 3 | 2018 | 34 | 0.380 |
Why?
| | AMP-Activated Protein Kinases | 4 | 2014 | 156 | 0.380 |
Why?
| | Energy Metabolism | 5 | 2019 | 930 | 0.360 |
Why?
| | Sevelamer | 2 | 2020 | 9 | 0.360 |
Why?
| | Thioredoxin Reductase 1 | 2 | 2019 | 5 | 0.360 |
Why?
| | Colitis | 2 | 2021 | 214 | 0.360 |
Why?
| | Cholangitis, Sclerosing | 2 | 2020 | 64 | 0.360 |
Why?
| | Lipids | 7 | 2019 | 628 | 0.360 |
Why?
| | Lung Injury | 2 | 2021 | 222 | 0.350 |
Why?
| | Gene Expression Regulation, Enzymologic | 4 | 2021 | 318 | 0.350 |
Why?
| | Skin Neoplasms | 3 | 2022 | 763 | 0.350 |
Why?
| | Ultraviolet Rays | 4 | 2022 | 413 | 0.340 |
Why?
| | Taste | 2 | 2021 | 255 | 0.340 |
Why?
| | Aldehyde Dehydrogenase, Mitochondrial | 5 | 2020 | 33 | 0.340 |
Why?
| | Leptin | 2 | 2020 | 238 | 0.330 |
Why?
| | Rats | 18 | 2022 | 6191 | 0.330 |
Why?
| | Gene Expression Regulation | 10 | 2021 | 2568 | 0.330 |
Why?
| | Macrophages | 6 | 2021 | 1325 | 0.330 |
Why?
| | Ovary | 3 | 2020 | 193 | 0.320 |
Why?
| | Lung | 7 | 2022 | 3580 | 0.320 |
Why?
| | Lipid Peroxidation | 5 | 2014 | 156 | 0.320 |
Why?
| | Genetic Vectors | 4 | 2010 | 321 | 0.310 |
Why?
| | Epithelial Cells | 7 | 2022 | 1016 | 0.310 |
Why?
| | Immunity, Innate | 4 | 2022 | 742 | 0.310 |
Why?
| | Triglycerides | 8 | 2021 | 540 | 0.300 |
Why?
| | Lipid Droplets | 4 | 2019 | 22 | 0.300 |
Why?
| | Blister | 4 | 2014 | 46 | 0.300 |
Why?
| | Irritants | 2 | 2017 | 32 | 0.300 |
Why?
| | Mice, Hairless | 9 | 2017 | 77 | 0.300 |
Why?
| | Carcinoma, Pancreatic Ductal | 2 | 2020 | 191 | 0.300 |
Why?
| | Proto-Oncogene Proteins c-akt | 3 | 2019 | 458 | 0.290 |
Why?
| | Down Syndrome | 2 | 2020 | 316 | 0.290 |
Why?
| | HEK293 Cells | 5 | 2021 | 649 | 0.290 |
Why?
| | Female | 52 | 2022 | 63300 | 0.290 |
Why?
| | Aldehyde Oxidoreductases | 3 | 2010 | 45 | 0.290 |
Why?
| | Glycoproteins | 4 | 2021 | 337 | 0.280 |
Why?
| | Dioxanes | 2 | 2021 | 9 | 0.280 |
Why?
| | Pancreatic Neoplasms | 4 | 2020 | 728 | 0.280 |
Why?
| | Transduction, Genetic | 3 | 2003 | 136 | 0.280 |
Why?
| | Immunohistochemistry | 13 | 2018 | 1784 | 0.280 |
Why?
| | Endoplasmic Reticulum | 5 | 2019 | 256 | 0.280 |
Why?
| | Renal Insufficiency, Chronic | 2 | 2022 | 501 | 0.270 |
Why?
| | Glycine | 2 | 2016 | 157 | 0.270 |
Why?
| | Signal Transduction | 13 | 2021 | 4905 | 0.270 |
Why?
| | Humans | 55 | 2022 | 115152 | 0.260 |
Why?
| | Oxygen | 3 | 2018 | 882 | 0.260 |
Why?
| | Glycolipids | 2 | 2016 | 41 | 0.260 |
Why?
| | Silymarin | 2 | 2016 | 211 | 0.260 |
Why?
| | Protein Processing, Post-Translational | 4 | 2017 | 425 | 0.260 |
Why?
| | Lipoproteins | 2 | 2021 | 169 | 0.260 |
Why?
| | Gene Deletion | 4 | 2018 | 382 | 0.260 |
Why?
| | Proteomics | 5 | 2021 | 775 | 0.250 |
Why?
| | Carcinoma, Squamous Cell | 3 | 2018 | 558 | 0.250 |
Why?
| | Glutathione | 7 | 2021 | 335 | 0.250 |
Why?
| | Cell Line | 14 | 2022 | 2930 | 0.250 |
Why?
| | Microtubule-Associated Proteins | 5 | 2019 | 195 | 0.250 |
Why?
| | Mitochondrial Proteins | 2 | 2015 | 231 | 0.250 |
Why?
| | Patched-1 Receptor | 2 | 2022 | 17 | 0.250 |
Why?
| | Oxidative Phosphorylation | 3 | 2021 | 157 | 0.250 |
Why?
| | Alprostadil | 4 | 1992 | 39 | 0.250 |
Why?
| | Corpus Luteum | 4 | 1992 | 28 | 0.240 |
Why?
| | NF-kappa B | 3 | 2022 | 723 | 0.240 |
Why?
| | Catalase | 3 | 2017 | 135 | 0.240 |
Why?
| | Mast Cells | 4 | 2019 | 120 | 0.240 |
Why?
| | Phospholipids | 2 | 2017 | 205 | 0.240 |
Why?
| | Diabetic Nephropathies | 2 | 2017 | 276 | 0.240 |
Why?
| | Diet, Western | 2 | 2020 | 50 | 0.240 |
Why?
| | Dermatitis, Contact | 2 | 2013 | 28 | 0.240 |
Why?
| | Antidotes | 2 | 2015 | 139 | 0.230 |
Why?
| | Membrane Glycoproteins | 4 | 2021 | 495 | 0.230 |
Why?
| | Nucleotides | 2 | 2021 | 114 | 0.230 |
Why?
| | Weight Gain | 4 | 2019 | 496 | 0.230 |
Why?
| | Cell Membrane | 5 | 2016 | 748 | 0.230 |
Why?
| | Herpesvirus 3, Human | 2 | 2021 | 392 | 0.230 |
Why?
| | Proteins | 6 | 2013 | 954 | 0.230 |
Why?
| | RNA, Messenger | 10 | 2021 | 2836 | 0.230 |
Why?
| | Pneumonia, Pneumococcal | 1 | 2022 | 36 | 0.230 |
Why?
| | Hepatitis, Alcoholic | 1 | 2021 | 12 | 0.230 |
Why?
| | Thermogenesis | 2 | 2019 | 46 | 0.230 |
Why?
| | Colon | 2 | 2020 | 221 | 0.220 |
Why?
| | Phosphorylation | 6 | 2020 | 1734 | 0.220 |
Why?
| | Cell Proliferation | 11 | 2020 | 2373 | 0.220 |
Why?
| | Colonic Neoplasms | 3 | 2011 | 217 | 0.220 |
Why?
| | Phytosterols | 1 | 2021 | 11 | 0.220 |
Why?
| | Isoxazoles | 1 | 2021 | 59 | 0.220 |
Why?
| | Bacterial Toxins | 1 | 2022 | 111 | 0.220 |
Why?
| | Alcoholic Intoxication | 1 | 2022 | 74 | 0.220 |
Why?
| | Cell Culture Techniques | 2 | 2018 | 354 | 0.220 |
Why?
| | Phenylurea Compounds | 1 | 2022 | 90 | 0.210 |
Why?
| | Blotting, Western | 9 | 2015 | 1294 | 0.210 |
Why?
| | Drug Resistance | 1 | 2022 | 185 | 0.210 |
Why?
| | Peroxiredoxins | 2 | 2018 | 23 | 0.210 |
Why?
| | Pneumococcal Infections | 1 | 2022 | 98 | 0.210 |
Why?
| | Eye | 1 | 2022 | 105 | 0.210 |
Why?
| | Adrenal Glands | 1 | 2021 | 85 | 0.210 |
Why?
| | NF-E2-Related Factor 2 | 2 | 2019 | 81 | 0.210 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 25 | 0.210 |
Why?
| | 3T3 Cells | 4 | 2003 | 156 | 0.210 |
Why?
| | Adipose Tissue, Brown | 2 | 2019 | 73 | 0.210 |
Why?
| | Receptors, Vasopressin | 1 | 2021 | 33 | 0.210 |
Why?
| | Mucoproteins | 1 | 2020 | 10 | 0.210 |
Why?
| | Hepatitis | 2 | 2019 | 50 | 0.210 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 35 | 0.210 |
Why?
| | Energy Intake | 3 | 2021 | 507 | 0.210 |
Why?
| | Azetidines | 1 | 2020 | 39 | 0.210 |
Why?
| | Tumor Necrosis Factor-alpha | 3 | 2021 | 1241 | 0.210 |
Why?
| | Quinolines | 1 | 2022 | 140 | 0.210 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 3 | 2016 | 65 | 0.210 |
Why?
| | Biomarkers, Tumor | 3 | 2016 | 1060 | 0.210 |
Why?
| | Momordica charantia | 1 | 2020 | 16 | 0.210 |
Why?
| | Adenomatous Polyposis Coli | 1 | 2020 | 31 | 0.210 |
Why?
| | Positive Regulatory Domain I-Binding Factor 1 | 1 | 2020 | 23 | 0.200 |
Why?
| | Kidney Tubules | 2 | 2019 | 126 | 0.200 |
Why?
| | Sugars | 1 | 2020 | 15 | 0.200 |
Why?
| | Carcinogens | 2 | 2013 | 111 | 0.200 |
Why?
| | Case-Control Studies | 5 | 2020 | 3261 | 0.200 |
Why?
| | Apoptosis | 10 | 2020 | 2616 | 0.200 |
Why?
| | Lymphatic Vessels | 1 | 2020 | 54 | 0.200 |
Why?
| | Dietary Sucrose | 1 | 2020 | 52 | 0.200 |
Why?
| | Myometrium | 1 | 2020 | 36 | 0.200 |
Why?
| | PPAR alpha | 3 | 2016 | 58 | 0.200 |
Why?
| | Lipoproteins, LDL | 1 | 2020 | 151 | 0.200 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2016 | 339 | 0.200 |
Why?
| | Intestines | 3 | 2020 | 310 | 0.200 |
Why?
| | Monocytes | 2 | 2021 | 513 | 0.200 |
Why?
| | Protein Biosynthesis | 3 | 2001 | 413 | 0.200 |
Why?
| | Vasopressins | 1 | 2021 | 147 | 0.190 |
Why?
| | Melanocytes | 1 | 2020 | 69 | 0.190 |
Why?
| | SNARE Proteins | 1 | 2019 | 34 | 0.190 |
Why?
| | Gastrointestinal Motility | 1 | 2019 | 25 | 0.190 |
Why?
| | Electron Microscope Tomography | 1 | 2019 | 38 | 0.190 |
Why?
| | Cytochrome P-450 CYP2E1 | 4 | 2021 | 37 | 0.190 |
Why?
| | Deoxycytidine | 1 | 2020 | 146 | 0.190 |
Why?
| | Herpesviridae Infections | 1 | 2021 | 171 | 0.190 |
Why?
| | Cell Adhesion Molecules | 1 | 2020 | 184 | 0.190 |
Why?
| | Sucrose | 3 | 2018 | 145 | 0.190 |
Why?
| | Cholesterol, Dietary | 1 | 2019 | 25 | 0.190 |
Why?
| | Body Weight Maintenance | 1 | 2019 | 21 | 0.190 |
Why?
| | Ileum | 1 | 2019 | 92 | 0.190 |
Why?
| | Acylation | 1 | 2019 | 36 | 0.180 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2020 | 1200 | 0.180 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2020 | 466 | 0.180 |
Why?
| | Up-Regulation | 6 | 2022 | 941 | 0.180 |
Why?
| | Leishmania major | 1 | 2018 | 5 | 0.180 |
Why?
| | Leishmaniasis, Cutaneous | 1 | 2018 | 8 | 0.180 |
Why?
| | Kupffer Cells | 1 | 2019 | 56 | 0.180 |
Why?
| | Adipose Tissue | 3 | 2019 | 680 | 0.180 |
Why?
| | Thyroid Neoplasms | 1 | 2022 | 243 | 0.180 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2022 | 519 | 0.180 |
Why?
| | Cytokines | 5 | 2022 | 1964 | 0.180 |
Why?
| | Emphysema | 1 | 2019 | 110 | 0.180 |
Why?
| | Plant Extracts | 1 | 2020 | 173 | 0.180 |
Why?
| | Biomarkers | 6 | 2021 | 3509 | 0.180 |
Why?
| | Autophagy | 2 | 2019 | 317 | 0.180 |
Why?
| | Bone Morphogenetic Protein 2 | 1 | 2019 | 94 | 0.180 |
Why?
| | Fructose Intolerance | 1 | 2018 | 5 | 0.180 |
Why?
| | Thioredoxin-Disulfide Reductase | 1 | 2018 | 14 | 0.180 |
Why?
| | Altitude Sickness | 1 | 2020 | 159 | 0.180 |
Why?
| | Models, Animal | 2 | 2022 | 391 | 0.180 |
Why?
| | Arteries | 1 | 2020 | 236 | 0.180 |
Why?
| | Antineoplastic Agents, Phytogenic | 2 | 2019 | 194 | 0.180 |
Why?
| | Liver Cirrhosis | 3 | 2021 | 206 | 0.180 |
Why?
| | Carbohydrate Metabolism | 1 | 2018 | 59 | 0.180 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2020 | 894 | 0.170 |
Why?
| | Cold Temperature | 1 | 2019 | 158 | 0.170 |
Why?
| | Adenocarcinoma | 3 | 2011 | 814 | 0.170 |
Why?
| | Adipose Tissue, White | 1 | 2018 | 39 | 0.170 |
Why?
| | Uric Acid | 1 | 2021 | 353 | 0.170 |
Why?
| | Intestine, Small | 2 | 2020 | 145 | 0.170 |
Why?
| | Nitric Oxide | 3 | 2020 | 894 | 0.170 |
Why?
| | Glucose | 3 | 2019 | 909 | 0.170 |
Why?
| | Bile Ducts | 1 | 2018 | 73 | 0.170 |
Why?
| | Hep G2 Cells | 4 | 2021 | 77 | 0.170 |
Why?
| | Desoxycorticosterone Acetate | 1 | 2017 | 2 | 0.170 |
Why?
| | Nanoparticles | 1 | 2022 | 333 | 0.170 |
Why?
| | Relaxin | 1 | 2017 | 13 | 0.170 |
Why?
| | Gene Knockout Techniques | 1 | 2018 | 118 | 0.170 |
Why?
| | Oxidation-Reduction | 5 | 2021 | 981 | 0.170 |
Why?
| | Glucosides | 1 | 2018 | 39 | 0.170 |
Why?
| | Protein Kinases | 1 | 2020 | 337 | 0.170 |
Why?
| | Sodium Chloride, Dietary | 1 | 2018 | 43 | 0.170 |
Why?
| | Hypothalamo-Hypophyseal System | 1 | 2020 | 270 | 0.170 |
Why?
| | Proteome | 2 | 2019 | 323 | 0.170 |
Why?
| | Insulin Resistance | 4 | 2019 | 1150 | 0.170 |
Why?
| | Benzhydryl Compounds | 1 | 2018 | 65 | 0.170 |
Why?
| | Intestinal Mucosa | 3 | 2016 | 521 | 0.170 |
Why?
| | Carcinoma, Hepatocellular | 1 | 2019 | 194 | 0.170 |
Why?
| | Tandem Mass Spectrometry | 5 | 2021 | 391 | 0.170 |
Why?
| | Acetyl-CoA Carboxylase | 2 | 2014 | 40 | 0.170 |
Why?
| | Phosphatidylethanolamine N-Methyltransferase | 1 | 2017 | 8 | 0.160 |
Why?
| | Phosgene | 1 | 2017 | 5 | 0.160 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2019 | 230 | 0.160 |
Why?
| | Cytochrome d Group | 1 | 2016 | 2 | 0.160 |
Why?
| | Oximes | 1 | 2017 | 17 | 0.160 |
Why?
| | Virulence Factors | 1 | 2018 | 139 | 0.160 |
Why?
| | Cytochrome b Group | 1 | 2016 | 14 | 0.160 |
Why?
| | Glutamate-Cysteine Ligase | 2 | 2022 | 18 | 0.160 |
Why?
| | Amino Acid Sequence | 7 | 2020 | 2161 | 0.160 |
Why?
| | Base Sequence | 6 | 2015 | 2280 | 0.160 |
Why?
| | Hypersensitivity | 1 | 2020 | 278 | 0.160 |
Why?
| | Reactive Oxygen Species | 3 | 2022 | 559 | 0.160 |
Why?
| | Mitochondria, Muscle | 1 | 2018 | 102 | 0.160 |
Why?
| | Zebrafish Proteins | 1 | 2020 | 277 | 0.160 |
Why?
| | Sulfonamides | 1 | 2020 | 455 | 0.160 |
Why?
| | Fatty Acids | 3 | 2016 | 433 | 0.160 |
Why?
| | Nephrosclerosis | 1 | 2016 | 7 | 0.160 |
Why?
| | Precancerous Conditions | 1 | 2018 | 168 | 0.160 |
Why?
| | End Stage Liver Disease | 1 | 2017 | 59 | 0.160 |
Why?
| | Apocrine Glands | 1 | 2016 | 7 | 0.160 |
Why?
| | Vasodilation | 1 | 2020 | 483 | 0.160 |
Why?
| | Metabolic Diseases | 1 | 2018 | 117 | 0.160 |
Why?
| | DNA Primers | 5 | 2015 | 579 | 0.160 |
Why?
| | Temperature | 2 | 2018 | 658 | 0.160 |
Why?
| | Chemical and Drug Induced Liver Injury, Chronic | 1 | 2016 | 7 | 0.160 |
Why?
| | Spleen | 2 | 2018 | 535 | 0.150 |
Why?
| | Xanthine Dehydrogenase | 1 | 2016 | 40 | 0.150 |
Why?
| | Zebrafish | 1 | 2020 | 405 | 0.150 |
Why?
| | Disease Progression | 6 | 2020 | 2494 | 0.150 |
Why?
| | Necrosis | 2 | 2015 | 227 | 0.150 |
Why?
| | Transcription, Genetic | 3 | 2005 | 1463 | 0.150 |
Why?
| | Homocystinuria | 1 | 2017 | 59 | 0.150 |
Why?
| | Metalloporphyrins | 2 | 2014 | 106 | 0.150 |
Why?
| | Salmonella enterica | 1 | 2016 | 47 | 0.150 |
Why?
| | Fatty Acids, Omega-6 | 1 | 2016 | 49 | 0.150 |
Why?
| | Cell Differentiation | 7 | 2020 | 1808 | 0.150 |
Why?
| | Rabbits | 10 | 2002 | 795 | 0.150 |
Why?
| | Choline | 1 | 2017 | 124 | 0.150 |
Why?
| | Estradiol | 4 | 1988 | 462 | 0.150 |
Why?
| | Gene Expression | 1 | 2021 | 1538 | 0.150 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 1996 | 65 | 0.150 |
Why?
| | Liver Cirrhosis, Alcoholic | 1 | 2015 | 19 | 0.150 |
Why?
| | Optical Imaging | 1 | 2016 | 58 | 0.150 |
Why?
| | Epithelium, Corneal | 1 | 2016 | 42 | 0.150 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2018 | 166 | 0.150 |
Why?
| | Biliary Atresia | 1 | 2018 | 215 | 0.150 |
Why?
| | Acetylcysteine | 2 | 2022 | 148 | 0.150 |
Why?
| | Disease Susceptibility | 2 | 2020 | 348 | 0.150 |
Why?
| | Lung Neoplasms | 3 | 2018 | 2199 | 0.150 |
Why?
| | Cells, Cultured | 10 | 2020 | 4291 | 0.150 |
Why?
| | Lysine | 1 | 2017 | 232 | 0.150 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2020 | 681 | 0.140 |
Why?
| | Peroxidase | 5 | 2015 | 197 | 0.140 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2017 | 222 | 0.140 |
Why?
| | Pelvis | 1 | 2016 | 79 | 0.140 |
Why?
| | Molecular Sequence Data | 7 | 2015 | 3014 | 0.140 |
Why?
| | Epidermis | 2 | 2014 | 150 | 0.140 |
Why?
| | Protein Structure, Tertiary | 3 | 2011 | 882 | 0.140 |
Why?
| | Fetal Growth Retardation | 1 | 2020 | 428 | 0.140 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2016 | 134 | 0.140 |
Why?
| | Space Flight | 1 | 2016 | 124 | 0.140 |
Why?
| | Recombinant Proteins | 3 | 2017 | 1422 | 0.140 |
Why?
| | Liver Neoplasms | 1 | 2019 | 463 | 0.140 |
Why?
| | Hematopoietic System | 1 | 2014 | 8 | 0.140 |
Why?
| | Severity of Illness Index | 2 | 2020 | 2853 | 0.140 |
Why?
| | MicroRNAs | 1 | 2021 | 615 | 0.140 |
Why?
| | Cell Division | 7 | 1988 | 858 | 0.140 |
Why?
| | Phenotype | 2 | 2020 | 2861 | 0.140 |
Why?
| | Cholesterol | 4 | 2020 | 381 | 0.140 |
Why?
| | Breast Feeding | 1 | 2018 | 346 | 0.140 |
Why?
| | Down-Regulation | 4 | 2022 | 666 | 0.140 |
Why?
| | Cytoprotection | 2 | 2015 | 58 | 0.140 |
Why?
| | Diet | 3 | 2018 | 1075 | 0.140 |
Why?
| | Mice, Transgenic | 5 | 2021 | 2108 | 0.140 |
Why?
| | Skin Diseases | 1 | 2017 | 153 | 0.140 |
Why?
| | Alanine Transaminase | 4 | 2016 | 154 | 0.130 |
Why?
| | Microscopy, Fluorescence | 1 | 2016 | 434 | 0.130 |
Why?
| | Mice, Inbred ICR | 3 | 2021 | 116 | 0.130 |
Why?
| | Vagina | 1 | 2016 | 159 | 0.130 |
Why?
| | 4-Nitroquinoline-1-oxide | 1 | 2013 | 5 | 0.130 |
Why?
| | Metabolism, Inborn Errors | 1 | 2014 | 37 | 0.130 |
Why?
| | Hyperkeratosis, Epidermolytic | 1 | 2014 | 22 | 0.130 |
Why?
| | Dermis | 1 | 2014 | 29 | 0.130 |
Why?
| | Protein Kinase Inhibitors | 1 | 2020 | 857 | 0.130 |
Why?
| | Prediabetic State | 1 | 2016 | 223 | 0.130 |
Why?
| | Colorectal Neoplasms | 1 | 2020 | 595 | 0.130 |
Why?
| | Tongue Neoplasms | 1 | 2013 | 22 | 0.130 |
Why?
| | Body Weight | 5 | 2016 | 1023 | 0.130 |
Why?
| | Cloning, Molecular | 4 | 2010 | 579 | 0.130 |
Why?
| | Kidney Tubules, Proximal | 1 | 2014 | 93 | 0.130 |
Why?
| | Stilbenes | 1 | 2013 | 37 | 0.130 |
Why?
| | Gastrointestinal Microbiome | 2 | 2020 | 455 | 0.130 |
Why?
| | Methylation | 1 | 2014 | 218 | 0.130 |
Why?
| | Kidney Diseases | 1 | 2018 | 402 | 0.130 |
Why?
| | Motor Activity | 1 | 2019 | 752 | 0.130 |
Why?
| | Weight Loss | 1 | 2019 | 707 | 0.120 |
Why?
| | Grape Seed Extract | 1 | 2013 | 46 | 0.120 |
Why?
| | Melanoma | 1 | 2020 | 718 | 0.120 |
Why?
| | Fallopian Tubes | 1 | 1993 | 17 | 0.120 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2016 | 135 | 0.120 |
Why?
| | Tetradecanoylphorbol Acetate | 2 | 1996 | 173 | 0.120 |
Why?
| | Chromatography, Liquid | 4 | 2017 | 340 | 0.120 |
Why?
| | Heart | 1 | 2017 | 691 | 0.120 |
Why?
| | Phosphoproteins | 2 | 2013 | 324 | 0.120 |
Why?
| | Anticarcinogenic Agents | 1 | 2013 | 76 | 0.120 |
Why?
| | Metabolomics | 4 | 2022 | 536 | 0.120 |
Why?
| | Lymphopenia | 1 | 2013 | 55 | 0.120 |
Why?
| | Inositol Phosphates | 3 | 1988 | 25 | 0.120 |
Why?
| | Isoproterenol | 1 | 2013 | 154 | 0.120 |
Why?
| | Middle Aged | 9 | 2020 | 28958 | 0.120 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2013 | 57 | 0.120 |
Why?
| | Organ Size | 4 | 2016 | 503 | 0.120 |
Why?
| | Protein Structure, Secondary | 3 | 2018 | 388 | 0.120 |
Why?
| | B-Lymphocytes | 1 | 2018 | 817 | 0.120 |
Why?
| | Coxsackie and Adenovirus Receptor-Like Membrane Protein | 2 | 2003 | 7 | 0.120 |
Why?
| | Mothers | 2 | 2018 | 614 | 0.120 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 466 | 0.120 |
Why?
| | Natural Killer T-Cells | 1 | 2013 | 56 | 0.120 |
Why?
| | Microfilament Proteins | 1 | 2013 | 134 | 0.120 |
Why?
| | Green Fluorescent Proteins | 3 | 2011 | 417 | 0.120 |
Why?
| | Testis | 1 | 1992 | 123 | 0.120 |
Why?
| | Perilipin-3 | 2 | 2008 | 5 | 0.110 |
Why?
| | Cattle | 6 | 2016 | 969 | 0.110 |
Why?
| | Eye Proteins | 2 | 2021 | 71 | 0.110 |
Why?
| | Reactive Nitrogen Species | 1 | 2011 | 23 | 0.110 |
Why?
| | DNA, Complementary | 3 | 2016 | 288 | 0.110 |
Why?
| | Myocardium | 1 | 2017 | 1087 | 0.110 |
Why?
| | Hibernation | 1 | 2012 | 70 | 0.110 |
Why?
| | Taurine | 1 | 2011 | 43 | 0.110 |
Why?
| | Administration, Cutaneous | 3 | 2017 | 124 | 0.110 |
Why?
| | Carrier Proteins | 3 | 2017 | 806 | 0.110 |
Why?
| | Arousal | 1 | 2012 | 204 | 0.110 |
Why?
| | Nasal Cavity | 1 | 2011 | 50 | 0.110 |
Why?
| | Olfactory Mucosa | 1 | 2011 | 59 | 0.110 |
Why?
| | Microtubules | 1 | 2013 | 244 | 0.110 |
Why?
| | Sciuridae | 1 | 2012 | 127 | 0.100 |
Why?
| | Neurons | 1 | 2019 | 1406 | 0.100 |
Why?
| | Mutation | 3 | 2020 | 3403 | 0.100 |
Why?
| | Acetaldehyde | 1 | 2010 | 34 | 0.100 |
Why?
| | Cohort Studies | 1 | 2020 | 5026 | 0.100 |
Why?
| | Chenodeoxycholic Acid | 2 | 2021 | 11 | 0.100 |
Why?
| | Heme Oxygenase-1 | 2 | 2021 | 50 | 0.100 |
Why?
| | Fibrosis | 3 | 2017 | 414 | 0.100 |
Why?
| | Glycolysis | 2 | 2021 | 228 | 0.100 |
Why?
| | Luminescent Proteins | 2 | 2001 | 182 | 0.100 |
Why?
| | Pregnancy | 6 | 2020 | 5316 | 0.100 |
Why?
| | Multidrug Resistance-Associated Proteins | 2 | 2021 | 38 | 0.100 |
Why?
| | Blood Proteins | 1 | 2012 | 260 | 0.100 |
Why?
| | Casein Kinase II | 1 | 2009 | 23 | 0.100 |
Why?
| | COS Cells | 2 | 2003 | 205 | 0.100 |
Why?
| | Peroxiredoxin VI | 1 | 2009 | 5 | 0.100 |
Why?
| | Mice, Inbred BALB C | 3 | 2018 | 1316 | 0.090 |
Why?
| | Hyaluronan Receptors | 1 | 2009 | 96 | 0.090 |
Why?
| | Immediate-Early Proteins | 1 | 2009 | 65 | 0.090 |
Why?
| | Protein Folding | 1 | 2011 | 310 | 0.090 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2015 | 1090 | 0.090 |
Why?
| | Recombinant Fusion Proteins | 2 | 2011 | 696 | 0.090 |
Why?
| | Neoplasm Invasiveness | 3 | 2020 | 452 | 0.090 |
Why?
| | Serine | 1 | 2009 | 130 | 0.090 |
Why?
| | Biomarkers, Pharmacological | 1 | 2008 | 29 | 0.090 |
Why?
| | Prospective Studies | 1 | 2020 | 6324 | 0.090 |
Why?
| | Mice, Obese | 2 | 2019 | 60 | 0.090 |
Why?
| | Viral Envelope Proteins | 1 | 2009 | 86 | 0.090 |
Why?
| | Cysteine Proteinase Inhibitors | 2 | 2014 | 58 | 0.090 |
Why?
| | Lysosomes | 2 | 2019 | 138 | 0.090 |
Why?
| | Organ Specificity | 3 | 2018 | 299 | 0.090 |
Why?
| | Alcoholism | 1 | 2015 | 819 | 0.090 |
Why?
| | Hypertension | 1 | 2017 | 1194 | 0.090 |
Why?
| | Exosomes | 1 | 2009 | 83 | 0.090 |
Why?
| | Oleic Acid | 1 | 2008 | 40 | 0.090 |
Why?
| | Mutant Proteins | 1 | 2008 | 104 | 0.090 |
Why?
| | Endoplasmic Reticulum Stress | 2 | 2019 | 94 | 0.090 |
Why?
| | Kidney Function Tests | 2 | 2019 | 159 | 0.090 |
Why?
| | Structure-Activity Relationship | 2 | 2008 | 553 | 0.090 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2018 | 1954 | 0.090 |
Why?
| | Rats, Sprague-Dawley | 4 | 2016 | 2962 | 0.080 |
Why?
| | Tumor Suppressor Proteins | 2 | 2020 | 285 | 0.080 |
Why?
| | Tissue Distribution | 3 | 2007 | 365 | 0.080 |
Why?
| | Chemokines | 2 | 2022 | 239 | 0.080 |
Why?
| | Adiposity | 2 | 2015 | 492 | 0.080 |
Why?
| | Muscle, Smooth | 2 | 2019 | 140 | 0.080 |
Why?
| | Urethane | 1 | 2007 | 35 | 0.080 |
Why?
| | Vasotocin | 1 | 2006 | 6 | 0.080 |
Why?
| | Affinity Labels | 3 | 1992 | 27 | 0.080 |
Why?
| | CCAAT-Enhancer-Binding Protein-beta | 1 | 2007 | 47 | 0.080 |
Why?
| | Muscle Tonus | 1 | 2006 | 23 | 0.080 |
Why?
| | Uterine Contraction | 1 | 2006 | 17 | 0.080 |
Why?
| | Lipogenesis | 2 | 2018 | 79 | 0.080 |
Why?
| | Sugar Phosphates | 1 | 1986 | 3 | 0.080 |
Why?
| | Adult | 9 | 2020 | 32204 | 0.080 |
Why?
| | Prostaglandins | 1 | 2006 | 90 | 0.080 |
Why?
| | Risk Factors | 1 | 2020 | 9105 | 0.080 |
Why?
| | Azides | 3 | 1992 | 47 | 0.080 |
Why?
| | Lizards | 1 | 2006 | 39 | 0.080 |
Why?
| | Nitric Oxide Synthase Type II | 3 | 2014 | 179 | 0.080 |
Why?
| | Tumor Cells, Cultured | 3 | 2020 | 1002 | 0.080 |
Why?
| | Mice, Nude | 2 | 2020 | 696 | 0.080 |
Why?
| | Ovarian Neoplasms | 1 | 2010 | 350 | 0.080 |
Why?
| | Amidinotransferases | 2 | 2016 | 2 | 0.070 |
Why?
| | Thermodynamics | 1 | 2008 | 439 | 0.070 |
Why?
| | Guanidinoacetate N-Methyltransferase | 2 | 2016 | 5 | 0.070 |
Why?
| | Acetylation | 2 | 2017 | 222 | 0.070 |
Why?
| | S-Adenosylhomocysteine | 2 | 2016 | 24 | 0.070 |
Why?
| | Feces | 2 | 2020 | 368 | 0.070 |
Why?
| | Kidney Glomerulus | 2 | 2018 | 118 | 0.070 |
Why?
| | CCAAT-Enhancer-Binding Protein-alpha | 1 | 2005 | 18 | 0.070 |
Why?
| | Bone Marrow | 1 | 2007 | 263 | 0.070 |
Why?
| | DNA Replication | 1 | 1987 | 213 | 0.070 |
Why?
| | S-Adenosylmethionine | 2 | 2016 | 60 | 0.070 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 174 | 0.070 |
Why?
| | Perilipin-1 | 2 | 2019 | 18 | 0.070 |
Why?
| | Macrophage Activation | 2 | 2021 | 166 | 0.070 |
Why?
| | Sequence Analysis, RNA | 2 | 2018 | 405 | 0.070 |
Why?
| | Homocysteine | 2 | 2016 | 138 | 0.070 |
Why?
| | Adenoma | 1 | 2007 | 186 | 0.070 |
Why?
| | Chronic Disease | 1 | 2011 | 1650 | 0.070 |
Why?
| | Edema | 2 | 2017 | 123 | 0.070 |
Why?
| | Transforming Growth Factor beta | 2 | 2020 | 463 | 0.070 |
Why?
| | Diabetes Mellitus | 2 | 2018 | 948 | 0.070 |
Why?
| | Oxygen Consumption | 2 | 2018 | 660 | 0.070 |
Why?
| | Rats, Wistar | 2 | 2016 | 401 | 0.070 |
Why?
| | Tamoxifen | 2 | 2020 | 203 | 0.070 |
Why?
| | Diet, Fat-Restricted | 2 | 2015 | 86 | 0.070 |
Why?
| | Cyclic GMP | 2 | 2019 | 129 | 0.070 |
Why?
| | Polymerase Chain Reaction | 2 | 1998 | 1048 | 0.060 |
Why?
| | Transcription Factors | 3 | 2019 | 1623 | 0.060 |
Why?
| | Cyclooxygenase 2 | 2 | 2015 | 198 | 0.060 |
Why?
| | Urinary Bladder Neoplasms | 2 | 2005 | 192 | 0.060 |
Why?
| | Mammary Glands, Human | 2 | 2016 | 79 | 0.060 |
Why?
| | Gene Expression Profiling | 3 | 2017 | 1582 | 0.060 |
Why?
| | Macrophages, Alveolar | 1 | 2007 | 360 | 0.060 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2005 | 372 | 0.060 |
Why?
| | Time Factors | 5 | 2015 | 7041 | 0.060 |
Why?
| | Sequence Deletion | 1 | 2003 | 192 | 0.060 |
Why?
| | Chemokine CCL7 | 1 | 2022 | 4 | 0.060 |
Why?
| | Buthionine Sulfoximine | 1 | 2022 | 7 | 0.060 |
Why?
| | Inhibitor of Apoptosis Proteins | 4 | 2003 | 49 | 0.060 |
Why?
| | 8-Bromo Cyclic Adenosine Monophosphate | 2 | 1996 | 24 | 0.060 |
Why?
| | Fluorine | 2 | 1992 | 17 | 0.060 |
Why?
| | Antigens, CD | 2 | 2005 | 491 | 0.060 |
Why?
| | Adenovirus E1A Proteins | 1 | 2001 | 11 | 0.060 |
Why?
| | Carcinoma, Transitional Cell | 1 | 2002 | 45 | 0.060 |
Why?
| | Cell Survival | 4 | 2014 | 1139 | 0.060 |
Why?
| | Cervical Intraepithelial Neoplasia | 1 | 2002 | 27 | 0.060 |
Why?
| | Sterols | 1 | 2021 | 17 | 0.060 |
Why?
| | Cervix Uteri | 1 | 2002 | 46 | 0.060 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2003 | 177 | 0.060 |
Why?
| | Nuclear Receptor Co-Repressor 1 | 1 | 2021 | 16 | 0.060 |
Why?
| | Adenoviruses, Human | 1 | 2001 | 27 | 0.060 |
Why?
| | Heme | 1 | 2021 | 40 | 0.060 |
Why?
| | Rats, Inbred F344 | 2 | 1992 | 290 | 0.060 |
Why?
| | Immune Sera | 2 | 1992 | 81 | 0.060 |
Why?
| | Systems Analysis | 1 | 2021 | 23 | 0.060 |
Why?
| | Sodium Glutamate | 1 | 2021 | 13 | 0.060 |
Why?
| | Intestinal Diseases | 1 | 2021 | 32 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 2 | 2007 | 393 | 0.060 |
Why?
| | PAX6 Transcription Factor | 1 | 2021 | 22 | 0.060 |
Why?
| | I-kappa B Proteins | 1 | 2022 | 86 | 0.060 |
Why?
| | Bilirubin | 1 | 2021 | 88 | 0.060 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 2021 | 87 | 0.060 |
Why?
| | Homeostasis | 2 | 2016 | 594 | 0.050 |
Why?
| | Dilatation | 1 | 2022 | 53 | 0.050 |
Why?
| | Chromosomal Proteins, Non-Histone | 1 | 2002 | 106 | 0.050 |
Why?
| | Macaca fascicularis | 1 | 2021 | 46 | 0.050 |
Why?
| | Infliximab | 1 | 2021 | 90 | 0.050 |
Why?
| | Silicon Dioxide | 1 | 2022 | 90 | 0.050 |
Why?
| | Cation Exchange Resins | 1 | 2001 | 7 | 0.050 |
Why?
| | Histological Techniques | 1 | 2021 | 43 | 0.050 |
Why?
| | Polylysine | 1 | 2001 | 17 | 0.050 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2021 | 147 | 0.050 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2021 | 142 | 0.050 |
Why?
| | Drinking | 1 | 2021 | 47 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2015 | 2187 | 0.050 |
Why?
| | Indicators and Reagents | 1 | 2001 | 107 | 0.050 |
Why?
| | Gene Expression Regulation, Viral | 1 | 2001 | 103 | 0.050 |
Why?
| | Hedgehog Proteins | 1 | 2022 | 172 | 0.050 |
Why?
| | Plant Oils | 1 | 2000 | 29 | 0.050 |
Why?
| | Intestine, Large | 1 | 2020 | 14 | 0.050 |
Why?
| | Ursodeoxycholic Acid | 1 | 2020 | 19 | 0.050 |
Why?
| | Intercellular Junctions | 1 | 2020 | 31 | 0.050 |
Why?
| | Streptococcus pneumoniae | 1 | 2022 | 132 | 0.050 |
Why?
| | Proteostasis | 1 | 2020 | 17 | 0.050 |
Why?
| | Genes, Transgenic, Suicide | 1 | 2020 | 7 | 0.050 |
Why?
| | Receptors, Purinergic P2X2 | 1 | 2020 | 20 | 0.050 |
Why?
| | Pyrones | 1 | 2020 | 9 | 0.050 |
Why?
| | Dextran Sulfate | 1 | 2020 | 72 | 0.050 |
Why?
| | Receptors, Purinergic P2X3 | 1 | 2020 | 21 | 0.050 |
Why?
| | Forkhead Transcription Factors | 1 | 2021 | 180 | 0.050 |
Why?
| | Fluorescence | 1 | 2001 | 168 | 0.050 |
Why?
| | Promoter Regions, Genetic | 2 | 2005 | 1238 | 0.050 |
Why?
| | Morphogenesis | 1 | 2021 | 175 | 0.050 |
Why?
| | Feeding Behavior | 2 | 2018 | 558 | 0.050 |
Why?
| | Leukocytes | 1 | 2022 | 293 | 0.050 |
Why?
| | Aged | 5 | 2018 | 20309 | 0.050 |
Why?
| | Gene Knockdown Techniques | 1 | 2021 | 322 | 0.050 |
Why?
| | Permeability | 1 | 2020 | 160 | 0.050 |
Why?
| | Lactobacillus | 1 | 2020 | 25 | 0.050 |
Why?
| | Calcium | 1 | 2006 | 1208 | 0.050 |
Why?
| | Cecum | 1 | 2020 | 40 | 0.050 |
Why?
| | Cytomegalovirus | 1 | 2001 | 139 | 0.050 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2020 | 86 | 0.050 |
Why?
| | Epithelial-Mesenchymal Transition | 1 | 2022 | 171 | 0.050 |
Why?
| | DNA-Binding Proteins | 2 | 2019 | 1426 | 0.050 |
Why?
| | Ki-67 Antigen | 2 | 2016 | 108 | 0.050 |
Why?
| | Biphenyl Compounds | 1 | 2020 | 58 | 0.050 |
Why?
| | R-SNARE Proteins | 1 | 2019 | 22 | 0.050 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2019 | 30 | 0.050 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 191 | 0.050 |
Why?
| | Cell Line, Tumor | 3 | 2016 | 2890 | 0.050 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 134 | 0.050 |
Why?
| | Thiophenes | 1 | 2020 | 104 | 0.050 |
Why?
| | Uterine Cervical Neoplasms | 1 | 2002 | 204 | 0.050 |
Why?
| | Uncoupling Protein 1 | 1 | 2019 | 16 | 0.050 |
Why?
| | Purines | 1 | 2020 | 166 | 0.050 |
Why?
| | Iodide Peroxidase | 1 | 2019 | 30 | 0.050 |
Why?
| | Pituitary Gland | 1 | 2020 | 171 | 0.050 |
Why?
| | Collagen Type I | 1 | 2020 | 135 | 0.050 |
Why?
| | Alanine | 1 | 2019 | 106 | 0.050 |
Why?
| | Binding Sites | 1 | 2003 | 1292 | 0.050 |
Why?
| | Leishmania donovani | 1 | 2018 | 3 | 0.050 |
Why?
| | Interferon-alpha | 1 | 2020 | 211 | 0.050 |
Why?
| | Parasite Load | 1 | 2018 | 9 | 0.050 |
Why?
| | Polymers | 2 | 2014 | 479 | 0.050 |
Why?
| | Cyclin D1 | 1 | 2019 | 68 | 0.050 |
Why?
| | Photoperiod | 1 | 2019 | 61 | 0.050 |
Why?
| | Sirtuins | 1 | 2019 | 37 | 0.050 |
Why?
| | Interleukin-1beta | 1 | 2021 | 417 | 0.050 |
Why?
| | gamma Catenin | 1 | 2018 | 20 | 0.050 |
Why?
| | Desmoglein 3 | 1 | 2018 | 16 | 0.050 |
Why?
| | Protein Binding | 3 | 2011 | 2056 | 0.050 |
Why?
| | Breast Neoplasms | 1 | 2010 | 1934 | 0.050 |
Why?
| | Single-Cell Analysis | 1 | 2020 | 193 | 0.050 |
Why?
| | Drug Therapy, Combination | 1 | 2022 | 1007 | 0.040 |
Why?
| | Metaplasia | 1 | 2018 | 58 | 0.040 |
Why?
| | Food Preferences | 1 | 2020 | 143 | 0.040 |
Why?
| | beta Catenin | 1 | 2020 | 226 | 0.040 |
Why?
| | Fructose-Bisphosphate Aldolase | 1 | 2018 | 8 | 0.040 |
Why?
| | Chemoprevention | 1 | 2019 | 92 | 0.040 |
Why?
| | Sirtuin 3 | 1 | 2019 | 46 | 0.040 |
Why?
| | Sarcopenia | 1 | 2019 | 56 | 0.040 |
Why?
| | Bronchial Diseases | 1 | 2018 | 36 | 0.040 |
Why?
| | Ribosomes | 1 | 2019 | 161 | 0.040 |
Why?
| | Peptide Fragments | 1 | 2003 | 736 | 0.040 |
Why?
| | Mice, 129 Strain | 1 | 2018 | 84 | 0.040 |
Why?
| | Cell Respiration | 1 | 2018 | 79 | 0.040 |
Why?
| | Cell Cycle Checkpoints | 1 | 2018 | 90 | 0.040 |
Why?
| | Cholic Acids | 1 | 2017 | 15 | 0.040 |
Why?
| | Glomerular Mesangium | 1 | 2017 | 18 | 0.040 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2019 | 213 | 0.040 |
Why?
| | Adiponectin | 2 | 2013 | 209 | 0.040 |
Why?
| | Oligonucleotides, Antisense | 1 | 1998 | 104 | 0.040 |
Why?
| | Protein Transport | 1 | 2019 | 445 | 0.040 |
Why?
| | Interleukin-6 | 1 | 2022 | 706 | 0.040 |
Why?
| | Azo Compounds | 1 | 2017 | 28 | 0.040 |
Why?
| | Virulence | 1 | 2018 | 239 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2020 | 779 | 0.040 |
Why?
| | Mice, Inbred DBA | 1 | 2017 | 204 | 0.040 |
Why?
| | Sodium-Phosphate Cotransporter Proteins, Type I | 1 | 2017 | 3 | 0.040 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 20 | 0.040 |
Why?
| | Urinalysis | 1 | 2017 | 61 | 0.040 |
Why?
| | Heart Function Tests | 1 | 2017 | 76 | 0.040 |
Why?
| | Islets of Langerhans | 1 | 2003 | 715 | 0.040 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2017 | 82 | 0.040 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2016 | 17 | 0.040 |
Why?
| | Podocytes | 1 | 2017 | 47 | 0.040 |
Why?
| | Adenine | 1 | 2019 | 254 | 0.040 |
Why?
| | Erythema | 1 | 2017 | 27 | 0.040 |
Why?
| | Pyrazoles | 1 | 2020 | 400 | 0.040 |
Why?
| | Immunoenzyme Techniques | 2 | 2011 | 224 | 0.040 |
Why?
| | Indomethacin | 2 | 2006 | 79 | 0.040 |
Why?
| | Butyrophilins | 1 | 2016 | 6 | 0.040 |
Why?
| | Staining and Labeling | 2 | 1992 | 168 | 0.040 |
Why?
| | Isoenzymes | 1 | 2018 | 356 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2019 | 463 | 0.040 |
Why?
| | Bronchi | 1 | 2018 | 238 | 0.040 |
Why?
| | Albuminuria | 1 | 2017 | 186 | 0.040 |
Why?
| | Blood Glucose | 2 | 2018 | 1903 | 0.040 |
Why?
| | DNA | 5 | 1986 | 1358 | 0.040 |
Why?
| | Chromosomes, Artificial, Yeast | 1 | 1996 | 6 | 0.040 |
Why?
| | Adaptive Immunity | 1 | 2018 | 170 | 0.040 |
Why?
| | Fibroblast Growth Factors | 1 | 2018 | 179 | 0.040 |
Why?
| | Models, Molecular | 2 | 2013 | 1546 | 0.040 |
Why?
| | Intracellular Membranes | 1 | 2016 | 83 | 0.040 |
Why?
| | Homeodomain Proteins | 1 | 2020 | 499 | 0.040 |
Why?
| | Okadaic Acid | 1 | 1996 | 12 | 0.040 |
Why?
| | Hybrid Cells | 1 | 1996 | 53 | 0.040 |
Why?
| | Hepatic Stellate Cells | 1 | 2016 | 13 | 0.040 |
Why?
| | Aspartate Aminotransferases | 1 | 2016 | 100 | 0.040 |
Why?
| | Connective Tissue | 1 | 2016 | 43 | 0.040 |
Why?
| | RNA-Binding Proteins | 1 | 2019 | 359 | 0.040 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 1996 | 166 | 0.040 |
Why?
| | Oxidoreductases | 1 | 2016 | 100 | 0.040 |
Why?
| | Tissue Array Analysis | 1 | 2016 | 56 | 0.040 |
Why?
| | Recurrence | 1 | 2019 | 990 | 0.040 |
Why?
| | Lentivirus | 1 | 2016 | 56 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2019 | 545 | 0.040 |
Why?
| | Golgi Apparatus | 1 | 1996 | 103 | 0.040 |
Why?
| | Metabolome | 1 | 2019 | 298 | 0.040 |
Why?
| | Systems Biology | 1 | 2016 | 54 | 0.040 |
Why?
| | Neutrophils | 1 | 2022 | 1348 | 0.040 |
Why?
| | Animals, Newborn | 1 | 2018 | 843 | 0.040 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2018 | 887 | 0.040 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2016 | 94 | 0.040 |
Why?
| | Survival Rate | 1 | 2020 | 1862 | 0.040 |
Why?
| | Glucose Intolerance | 1 | 2016 | 137 | 0.040 |
Why?
| | Deoxyguanosine | 1 | 2015 | 29 | 0.040 |
Why?
| | Calcium-Binding Proteins | 1 | 2016 | 217 | 0.040 |
Why?
| | Chemokine CXCL2 | 1 | 2014 | 50 | 0.040 |
Why?
| | Receptor, Platelet-Derived Growth Factor beta | 1 | 2014 | 25 | 0.030 |
Why?
| | Catalysis | 1 | 2016 | 306 | 0.030 |
Why?
| | Mutation, Missense | 1 | 2017 | 302 | 0.030 |
Why?
| | Genotype | 1 | 2020 | 1854 | 0.030 |
Why?
| | Chromosome Mapping | 1 | 1996 | 509 | 0.030 |
Why?
| | Tumor Burden | 1 | 2016 | 289 | 0.030 |
Why?
| | Cytochrome P-450 CYP4A | 1 | 2014 | 6 | 0.030 |
Why?
| | Kidney Cortex | 1 | 2014 | 27 | 0.030 |
Why?
| | Comet Assay | 1 | 2014 | 18 | 0.030 |
Why?
| | Biopsy | 1 | 2018 | 1050 | 0.030 |
Why?
| | Fatty Acid Synthases | 1 | 2014 | 32 | 0.030 |
Why?
| | Lipopolysaccharide Receptors | 1 | 2014 | 94 | 0.030 |
Why?
| | CD36 Antigens | 1 | 2014 | 40 | 0.030 |
Why?
| | Protein Isoforms | 1 | 2015 | 356 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1167 | 0.030 |
Why?
| | Cell Cycle Proteins | 1 | 2018 | 573 | 0.030 |
Why?
| | Computational Biology | 1 | 2017 | 481 | 0.030 |
Why?
| | Leukocyte Count | 1 | 2014 | 328 | 0.030 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2015 | 348 | 0.030 |
Why?
| | Skinfold Thickness | 1 | 2013 | 50 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2014 | 166 | 0.030 |
Why?
| | Electrocardiography | 1 | 2017 | 656 | 0.030 |
Why?
| | Matrix Metalloproteinases | 1 | 2014 | 92 | 0.030 |
Why?
| | Homocysteine S-Methyltransferase | 1 | 2013 | 5 | 0.030 |
Why?
| | Proto-Oncogene Proteins | 1 | 2018 | 715 | 0.030 |
Why?
| | In Situ Nick-End Labeling | 1 | 2013 | 138 | 0.030 |
Why?
| | Tetraspanin 28 | 2 | 2005 | 4 | 0.030 |
Why?
| | Progesterone | 2 | 1987 | 256 | 0.030 |
Why?
| | Exercise Therapy | 1 | 2018 | 372 | 0.030 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2014 | 123 | 0.030 |
Why?
| | RNA Interference | 1 | 2016 | 499 | 0.030 |
Why?
| | Kinetics | 3 | 1987 | 1759 | 0.030 |
Why?
| | Transcriptome | 1 | 2019 | 685 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 1996 | 735 | 0.030 |
Why?
| | Binding, Competitive | 3 | 1992 | 213 | 0.030 |
Why?
| | Tongue | 1 | 2013 | 79 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2013 | 25 | 0.030 |
Why?
| | Ketone Bodies | 1 | 2013 | 18 | 0.030 |
Why?
| | Betaine | 1 | 2013 | 63 | 0.030 |
Why?
| | Leydig Cells | 1 | 1992 | 16 | 0.030 |
Why?
| | Central Nervous System Depressants | 1 | 2014 | 119 | 0.030 |
Why?
| | Antigens, CD1d | 1 | 2013 | 53 | 0.030 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2015 | 476 | 0.030 |
Why?
| | Nucleic Acid Conformation | 1 | 1996 | 712 | 0.030 |
Why?
| | Cell Nucleus | 2 | 2009 | 611 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2019 | 5076 | 0.030 |
Why?
| | Theca Cells | 1 | 1992 | 2 | 0.030 |
Why?
| | Actins | 1 | 2014 | 368 | 0.030 |
Why?
| | Antibody Specificity | 1 | 1993 | 193 | 0.030 |
Why?
| | Dietary Supplements | 1 | 2016 | 454 | 0.030 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1377 | 0.030 |
Why?
| | alpha-Macroglobulins | 1 | 2012 | 21 | 0.030 |
Why?
| | Stress, Physiological | 1 | 2016 | 550 | 0.030 |
Why?
| | Antibodies | 1 | 2014 | 417 | 0.030 |
Why?
| | Aldehyde Reductase | 1 | 2013 | 106 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2016 | 612 | 0.030 |
Why?
| | Species Specificity | 1 | 2013 | 619 | 0.030 |
Why?
| | Carcinogenesis | 1 | 2013 | 161 | 0.030 |
Why?
| | Models, Chemical | 1 | 2014 | 297 | 0.030 |
Why?
| | Sex Factors | 1 | 2018 | 1977 | 0.030 |
Why?
| | Caseins | 1 | 2011 | 26 | 0.030 |
Why?
| | Follow-Up Studies | 1 | 2021 | 4959 | 0.030 |
Why?
| | Prognosis | 1 | 2020 | 3550 | 0.030 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 512 | 0.030 |
Why?
| | Amino Acids | 1 | 2015 | 426 | 0.030 |
Why?
| | Palmitic Acid | 1 | 2011 | 50 | 0.030 |
Why?
| | Mucous Membrane | 2 | 2002 | 117 | 0.030 |
Why?
| | Serum Albumin | 1 | 2012 | 161 | 0.030 |
Why?
| | Models, Biological | 2 | 2011 | 1812 | 0.030 |
Why?
| | Body Temperature | 1 | 2012 | 278 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2013 | 543 | 0.030 |
Why?
| | Insulin | 2 | 2016 | 2161 | 0.030 |
Why?
| | Lipase | 1 | 2011 | 80 | 0.030 |
Why?
| | Retinal Dehydrogenase | 1 | 2011 | 42 | 0.030 |
Why?
| | Enzyme Activation | 1 | 2013 | 959 | 0.030 |
Why?
| | Survival Analysis | 1 | 2014 | 1410 | 0.030 |
Why?
| | Tritium | 1 | 1990 | 81 | 0.030 |
Why?
| | Membranes, Artificial | 1 | 2011 | 76 | 0.030 |
Why?
| | Chromatography, Affinity | 1 | 1990 | 94 | 0.030 |
Why?
| | Cations, Divalent | 1 | 1990 | 56 | 0.030 |
Why?
| | Baculoviridae | 1 | 2010 | 50 | 0.030 |
Why?
| | NAD | 1 | 2010 | 49 | 0.030 |
Why?
| | Hypoxia | 1 | 2016 | 928 | 0.030 |
Why?
| | Blood Pressure | 1 | 2017 | 1728 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2022 | 2037 | 0.030 |
Why?
| | Mitochondria, Liver | 1 | 2010 | 86 | 0.020 |
Why?
| | Microscopy, Electron, Transmission | 1 | 2010 | 140 | 0.020 |
Why?
| | Hydrolysis | 1 | 1990 | 187 | 0.020 |
Why?
| | Insecta | 1 | 2010 | 65 | 0.020 |
Why?
| | Histones | 1 | 2015 | 539 | 0.020 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2010 | 148 | 0.020 |
Why?
| | Cell Death | 1 | 2011 | 337 | 0.020 |
Why?
| | Oxidants | 1 | 2010 | 129 | 0.020 |
Why?
| | Urokinase-Type Plasminogen Activator | 1 | 2009 | 35 | 0.020 |
Why?
| | Seasons | 1 | 2012 | 438 | 0.020 |
Why?
| | Cytosol | 1 | 2010 | 253 | 0.020 |
Why?
| | Culture Media, Conditioned | 1 | 2009 | 101 | 0.020 |
Why?
| | Protease Inhibitors | 1 | 1990 | 116 | 0.020 |
Why?
| | Transgenes | 1 | 2010 | 193 | 0.020 |
Why?
| | Administration, Inhalation | 1 | 2011 | 673 | 0.020 |
Why?
| | HeLa Cells | 2 | 2001 | 635 | 0.020 |
Why?
| | Plasmids | 1 | 2010 | 387 | 0.020 |
Why?
| | Prostaglandins F, Synthetic | 1 | 1989 | 9 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 2009 | 72 | 0.020 |
Why?
| | Proliferating Cell Nuclear Antigen | 1 | 2008 | 56 | 0.020 |
Why?
| | In Vitro Techniques | 2 | 1989 | 1231 | 0.020 |
Why?
| | Neutrophil Infiltration | 1 | 2008 | 106 | 0.020 |
Why?
| | Administration, Topical | 1 | 2008 | 156 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2018 | 1535 | 0.020 |
Why?
| | Cell Adhesion | 1 | 2009 | 468 | 0.020 |
Why?
| | Nuclear Proteins | 1 | 2013 | 634 | 0.020 |
Why?
| | Administration, Oral | 1 | 2010 | 798 | 0.020 |
Why?
| | Random Allocation | 1 | 2008 | 396 | 0.020 |
Why?
| | Palmitates | 1 | 2007 | 29 | 0.020 |
Why?
| | Reflex, Stretch | 1 | 2006 | 9 | 0.020 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 308 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2009 | 611 | 0.020 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2007 | 68 | 0.020 |
Why?
| | Cell Movement | 2 | 2009 | 933 | 0.020 |
Why?
| | Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1986 | 4 | 0.020 |
Why?
| | Vanadium | 1 | 1986 | 6 | 0.020 |
Why?
| | Carbachol | 1 | 1986 | 21 | 0.020 |
Why?
| | Vanadates | 1 | 1986 | 30 | 0.020 |
Why?
| | Exercise | 1 | 2018 | 1774 | 0.020 |
Why?
| | Prostaglandins E | 1 | 1986 | 50 | 0.020 |
Why?
| | Thymidine | 1 | 1986 | 59 | 0.020 |
Why?
| | Phosphoric Diester Hydrolases | 1 | 1986 | 45 | 0.020 |
Why?
| | Infant | 1 | 2019 | 8124 | 0.020 |
Why?
| | Growth Substances | 1 | 1986 | 140 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2007 | 354 | 0.020 |
Why?
| | Substrate Specificity | 1 | 2007 | 399 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2018 | 6845 | 0.020 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 1986 | 96 | 0.020 |
Why?
| | PPAR gamma | 1 | 2007 | 185 | 0.020 |
Why?
| | Tetraspanins | 1 | 2005 | 11 | 0.020 |
Why?
| | Epidermal Growth Factor | 1 | 1986 | 163 | 0.020 |
Why?
| | Antibodies, Viral | 1 | 2009 | 543 | 0.020 |
Why?
| | Peptide Hydrolases | 1 | 1986 | 100 | 0.020 |
Why?
| | Detergents | 1 | 2005 | 51 | 0.020 |
Why?
| | Dinoprostone | 1 | 1986 | 198 | 0.020 |
Why?
| | Uteroglobin | 2 | 1984 | 17 | 0.020 |
Why?
| | Cyclic AMP | 1 | 1986 | 285 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2008 | 1500 | 0.020 |
Why?
| | Solubility | 1 | 2005 | 267 | 0.020 |
Why?
| | Introns | 1 | 2005 | 245 | 0.020 |
Why?
| | Hydrocortisone | 1 | 1987 | 331 | 0.020 |
Why?
| | Multiprotein Complexes | 1 | 2005 | 150 | 0.020 |
Why?
| | Child, Preschool | 1 | 2018 | 9680 | 0.020 |
Why?
| | Genetic Predisposition to Disease | 1 | 2013 | 2197 | 0.020 |
Why?
| | Testosterone | 1 | 1987 | 325 | 0.020 |
Why?
| | Metformin | 1 | 2007 | 286 | 0.020 |
Why?
| | Glucagon | 1 | 2003 | 95 | 0.020 |
Why?
| | Uterine Cervical Dysplasia | 1 | 2002 | 19 | 0.010 |
Why?
| | Spectrometry, Fluorescence | 2 | 1979 | 183 | 0.010 |
Why?
| | Tumor Virus Infections | 1 | 2002 | 66 | 0.010 |
Why?
| | Aging | 1 | 1992 | 1711 | 0.010 |
Why?
| | Fibroblasts | 1 | 2007 | 869 | 0.010 |
Why?
| | In Situ Hybridization | 1 | 2002 | 329 | 0.010 |
Why?
| | Papillomaviridae | 1 | 2002 | 126 | 0.010 |
Why?
| | Estrogens | 1 | 1984 | 305 | 0.010 |
Why?
| | Photochemistry | 2 | 1992 | 139 | 0.010 |
Why?
| | Sheep | 3 | 1992 | 758 | 0.010 |
Why?
| | Fluorescent Dyes | 2 | 1979 | 306 | 0.010 |
Why?
| | Membrane Microdomains | 1 | 2000 | 42 | 0.010 |
Why?
| | Polyribosomes | 1 | 1980 | 25 | 0.010 |
Why?
| | Gestational Age | 1 | 2003 | 764 | 0.010 |
Why?
| | Hyperplasia | 1 | 2001 | 168 | 0.010 |
Why?
| | Keratins | 1 | 2001 | 183 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 2000 | 237 | 0.010 |
Why?
| | Molecular Structure | 2 | 1992 | 491 | 0.010 |
Why?
| | Thyrotropin | 1 | 1980 | 110 | 0.010 |
Why?
| | Cytological Techniques | 1 | 1979 | 23 | 0.010 |
Why?
| | Thyroid Gland | 1 | 1980 | 91 | 0.010 |
Why?
| | DNA, Viral | 1 | 2002 | 436 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 18716 | 0.010 |
Why?
| | Fetus | 1 | 2003 | 655 | 0.010 |
Why?
| | Child | 1 | 2018 | 17939 | 0.010 |
Why?
| | Chromomycins | 1 | 1978 | 1 | 0.010 |
Why?
| | Olivomycins | 1 | 1978 | 1 | 0.010 |
Why?
| | Plicamycin | 1 | 1978 | 3 | 0.010 |
Why?
| | Papillomavirus Infections | 1 | 2002 | 243 | 0.010 |
Why?
| | Hypoglycemic Agents | 1 | 2007 | 1032 | 0.010 |
Why?
| | Peptides, Cyclic | 1 | 1978 | 261 | 0.010 |
Why?
| | Polyethylene Glycols | 1 | 2000 | 579 | 0.010 |
Why?
| | Cell Cycle | 1 | 1978 | 590 | 0.010 |
Why?
| | RNA | 1 | 1980 | 780 | 0.010 |
Why?
| | Luteal Cells | 1 | 1992 | 4 | 0.010 |
Why?
| | Esters | 1 | 1992 | 56 | 0.010 |
Why?
| | Chemistry | 1 | 1989 | 40 | 0.010 |
Why?
| | Chemical Phenomena | 1 | 1989 | 88 | 0.010 |
Why?
| | Estrogen Antagonists | 1 | 1984 | 45 | 0.000 |
Why?
| | Receptors, Estrogen | 1 | 1984 | 391 | 0.000 |
Why?
| | Poly A | 1 | 1980 | 46 | 0.000 |
Why?
| | RNA, Ribosomal | 1 | 1980 | 168 | 0.000 |
Why?
| | Fixatives | 1 | 1978 | 16 | 0.000 |
Why?
| | Leukemia, Experimental | 1 | 1978 | 30 | 0.000 |
Why?
| | Cricetinae | 1 | 1978 | 287 | 0.000 |
Why?
| | Magnesium | 1 | 1978 | 157 | 0.000 |
Why?
| | Osmolar Concentration | 1 | 1978 | 228 | 0.000 |
Why?
| | Hydrogen-Ion Concentration | 1 | 1978 | 582 | 0.000 |
Why?
|
|
Orlicky's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|